We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.98B
AUM Growth
+$132M
Cap. Flow
+$20.2M
Cap. Flow %
0.34%
Top 10 Hldgs %
41.51%
Holding
666
New
23
Increased
324
Reduced
223
Closed
42

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$142M
2
ASML icon
ASML
ASML
+$117M
3
TSEM icon
Tower Semiconductor
TSEM
+$112M
4
LRCX icon
Lam Research
LRCX
+$88M
5
MU icon
Micron Technology
MU
+$53.9M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$81.3M
2
LITE icon
Lumentum
LITE
+$72.3M
3
PM icon
Philip Morris
PM
+$40M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
META icon
Meta Platforms (Facebook)
META
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 54.47%
2 Communication Services 12.44%
3 Consumer Discretionary 11.77%
4 Consumer Staples 6.03%
5 Healthcare 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GHRS icon
501
GH Research
GHRS
$1.95B
$19.5K ﹤0.01%
1,384
+166
+14% +$2.55K
FTRE icon
502
Fortrea Holdings
FTRE
$1.69B
$19.5K ﹤0.01%
2,065
+250
+14% +$3.21K
ABUS icon
503
Arbutus Biopharma
ABUS
$893M
$19.4K ﹤0.01%
4,300
+522
+14% +$2.28K
XNCR icon
504
Xencor
XNCR
$1.52B
$19.2K ﹤0.01%
1,593
+191
+14% +$2.37K
URGN icon
505
UroGen Pharma
URGN
$2.13B
$18.8K ﹤0.01%
1,045
+126
+14% +$2.53K
CGEM icon
506
Cullinan Oncology
CGEM
$1.11B
$18.7K ﹤0.01%
1,318
+158
+14% +$2.03K
JANX icon
507
Janux Therapeutics
JANX
$992M
$18.7K ﹤0.01%
1,342
+161
+14% +$2.21K
TBPH icon
508
Theravance Biopharma
TBPH
$873M
$18.3K ﹤0.01%
1,129
+134
+13% +$2.37K
ANNX icon
509
Annexon
ANNX
$883M
$17.9K ﹤0.01%
3,234
+391
+14% +$2.2K
UMH
510
UMH Properties
UMH
$1.32B
$17.8K ﹤0.01%
1,235
-102
-8% -$1.58K
CTMX icon
511
CytomX Therapeutics
CTMX
$745M
$17.8K ﹤0.01%
3,787
+458
+14% +$2.33K
SPRY icon
512
ARS Pharmaceuticals
SPRY
$632M
$17.7K ﹤0.01%
2,208
+266
+14% +$2.55K
PHAT icon
513
Phathom Pharmaceuticals
PHAT
$897M
$17.6K ﹤0.01%
1,588
+191
+14% +$2.41K
SANA icon
514
Sana Biotechnology
SANA
$879M
$17.2K ﹤0.01%
5,958
+724
+14% +$2.85K
DHC
515
Diversified Healthcare Trust
DHC
$2.33B
$17.2K ﹤0.01%
2,583
-217
-8% -$1.38K
MNKD icon
516
MannKind Corp
MNKD
$1.25B
$16.8K ﹤0.01%
6,870
+836
+14% +$3.73K
MESO
517
Mesoblast
MESO
$2.13B
$16.8K ﹤0.01%
1,093
+129
+13% +$2.15K
OMER icon
518
Omeros
OMER
$690M
$16.7K ﹤0.01%
1,583
+191
+14% +$2.25K
ZLAB icon
519
Zai Lab
ZLAB
$2.31B
$16.4K ﹤0.01%
873
+105
+14% +$1.95K
CSTL icon
520
Castle Biosciences
CSTL
$743M
$15.9K ﹤0.01%
648
+75
+13% +$2.46K
KURA icon
521
Kura Oncology
KURA
$967M
$15.8K ﹤0.01%
1,944
+234
+14% +$2.01K
MGTX icon
522
MeiraGTx Holdings
MGTX
$1.16B
$15.5K ﹤0.01%
1,795
+215
+14% +$1.63K
RLJ icon
523
RLJ Lodging Trust
RLJ
$1.86B
$15.4K ﹤0.01%
2,079
-175
-8% -$1.36K
MSA icon
524
Mine Safety
MSA
$6.56B
$15.4K ﹤0.01%
94
– –
ARVN icon
525
Arvinas
ARVN
$533M
$15.2K ﹤0.01%
1,434
+172
+14% +$2.13K
19 20
21
22 23

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, GF Fund Management held 666 positions worth $5.98B, up 2.3% from $5.85B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

GF Fund Management's Q1 2026 filing shows 23 new, 324 increased, 223 reduced and 42 closed positions. Its largest new stake was Coherent: 98,000 shares worth $23.3M. The largest sale was Sandisk, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 51% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q1 2026 buy was Coherent: 98,000 shares worth $23.3M.
  • GF Fund Management added most to Walmart Inc in Q1 2026, an estimated $142M increase.
  • GF Fund Management's biggest Q1 2026 reduction was Sandisk, cutting an estimated $81.3M.
  • GF Fund Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.4M.
  • GF Fund Management's ten largest holdings make up 42% of its $5.98B portfolio in Q1 2026.
  • GF Fund Management opened 23 new positions and closed 42 in Q1 2026.
  • GF Fund Management's portfolio value rose 2.3% quarter-over-quarter to $5.98B.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.